Feed NSB.AX
NS
NeuroScientific Biopharmaceuticals Limited
NSB.AX · ASX
$0.06 +0.00% (+$0.00)
1M -10.77%
Market Cap $23.4M
P/E Ratio -
Div. Yield -
ROE 23.85%
Bulios Fair Price
$0.03
50.0% downside
Preț actual
$0.06
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NSB.AX sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
100 /100
Cheap P/B 1.39x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 44.96%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 11.40%
ROE 23.85%
ROA 10.88%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 49.56x
Int. coverage N/A
Stability
27 /100
Unstable Beta 1.12x
EPS volatility 452.22%
Profitable years 0
Întreabă StockBot despre NSB.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Nathan Smith
Employees
9
Headquarters
Perth